Phase III trial in hepatitis B prevention.
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D006509:Hepatitis B / Q000517:prevention & control*; D017325:Hepatitis B Vaccines; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D012449:Safety; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D017325:Hepatitis B Vaccines